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Manuscript  
Abstract  
Objective: Critically ill adults develop significant muscle wasting, with subsequent worse outcomes. 
In the pediatric setting, occurrence and effects of muscle wasting are undescribed; this is in part due 
to a lack of validated, objective methods for assessing muscle wasting. Single measurement of 
quadriceps femoris (QF) thickness has failed to show consistent reproducibility. We hypothesised 
that averaging repeated measurements could afford good reproducibility to allow for QF thickness 
decline detection and monitoring. 
Design: Prospective bedside observational study. 
Setting: Two pediatric intensive care units (PICU’s). 
Patients: Mechanically ventilated critically ill children aged 0 to 15 years. 
Interventions: Transverse and longitudinal axis measurements of QF anterior thickness were 
undertaken using bedside ultrasound.  The average of 4 measurement values was recorded. The 
location of measurement was marked for consistency within subsequent measurements by the same 
or another trained operator, to assess intra- and inter-operator repeatability and reproducibility of 
the technique. Where feasible, serial measurements were undertaken until the time of extubation in 
a group of children with prolonged PICU stay (>5 days). 
Measurements and Main Results: Seventy-three children were enrolled to assess intra- and inter-
operator ultrasound reliability. Their median (25-75interquartiles) age and weight were 30 months 
(4.5-96) and 10 kg (5-23.5). In the intra-operator repeatability study, mean relative difference in QF 
muscle thickness was 0.36% +/-2.5 (lower and upper limits of agreement: -4.5/+5.2%). In the inter-
operator reproducibility study, intraclass correlation coefficient was 0.998. In the 17 children 
monitored over their PICU stay, QF thickness significantly decreased at day 5 by 9.8% (p=0.006), and 
by 13.3% (<0.001) at the last performed measurement. 
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Conclusions: QF thickness decrease, proposed as a surrogate for muscle mass, is an early, frequent 
and intense phenomenon in PICU. QF ultrasonography is a reliable technique to monitor this 
process, and in future could help to guide rehabilitation and nutrition interventions. 
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Introduction 
In critically ill patients, intensive care – acquired weakness (ICU-AW) corresponds to an acquired 
neuro-muscular disease that is potentially reversible. The pathophysiology of ICU-AW is multi-
factorial. It involves peripheral nerves alteration (neuropathy) that can lead to muscle wasting. It 
also involves myopathic features, characterized by muscle alteration and muscle wasting (1,2). First, 
muscle organ failure (resulting from hypoxia, compromised perfusion, and direct muscle injury) will 
induce the so called “acute muscle wasting”. This leads to muscle turnover metabolism alteration 
(including increased catabolism and decreased anabolism) and resultant increased muscle 
breakdown. In addition, disuse atrophy occurs in the comatose bedridden patient, under sedation or 
neuro-blocking agents. Furthermore, undernutrition is a constant challenge in the care of critical 
illness. This may be due to fluid restriction, intolerance to enteral feeding and elective suspension of 
enteral feeds prior to specific procedures or extubation. These are likely to increase muscle wasting 
from fasting. Finally, in patients who remain ill for extended periods, chronic cachexia also 
contributes to muscle wasting, as seen in non-critical chronic inflammatory diseases and patients 
with malignancies (1,3,4). 
In the adult setting, ICU-AW has been documented as a frequent, rapid and early phenomenon, 
especially in multi-organ failure (1). It prolongs ICU- and hospital- stay, as well as post-ICU 
rehabilitation, resulting in increased health care costs (5,6).  
In contrast, Pediatric Intensive Care – acquired weakness (PICU-AW) is not well studied. The medium 
to long term effects of muscle wasting in children are almost completely undescribed (7–11). This is 
in part due to a lack of validated, objective methods for screening and assessing muscle wasting in 
children admitted to PICU (12). 
Defining and validating accurate tools to assess PICU-muscle wasting is therefore essential in order 
to enable an accurate description of its incidence in the clinical setting. Furthermore, this will aid 
understanding of the underlying biological processes and functional implications, whilst also helping 
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to develop future therapeutic approaches to prevent and minimize PICU-muscle wasting (with the 
inclusion of feeding regimens, pharmaconutrition, early rehabilitation, etc). Classic methods for the 
assessment of muscle mass changes are neither accurate nor validated in the critically ill child (13). 
Firstly, bioimpedance analysis (BIA) of body composition is impacted by major fluid shifts and is not 
validated in critically ill infants and young children. In addition,  other methods such as DEXA or CT 
imaging are challenging to perform in an unstable child because of the requirement for specific 
equipment (13). Magnetic resonance imaging (MRI), considered the gold standard for the 
assessment of body composition, is also technically difficult to perform in the PICU setting and is not 
practical for use as a daily bedside muscle mass assessment tool (13).  
We aimed in this study to assess PICU muscle wasting over PICU stay, based on quadriceps femoris 
(QF) muscle thickness repeated measurements, as a surrogate for changes in muscle mass.  Muscle 
mass assessment using anterior thigh ultrasonography has been shown to be reliable in adults, but 
single measurements of quadriceps femoris muscle thickness have thus far failed to be reproducible 
in children (12). We hypothesized that by designing a detailed measurement protocol using anterior 
thigh ultrasonography, coupled with the use of multiple measurements of QF muscle thickness 
across different axes, we could improve the accuracy and reproducibility of the technique.  Thus 
allowing for the accurate assessment and serial monitoring of PICU muscle wasting over the course 
of critical illness. 
 
 
Material and methods 
We conducted a prospective observational study across two PICU’s (Lyon, France and Cambridge, 
United Kingdom) between November 2015 and April 2016. Intra- and inter-operator repeatability 
and reproducibility of QF muscle thickness measurement using anterior thigh ultrasonography were 
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assessed. Within each aspect of the study (intra- and inter- operator repeatability and 
reproducibility) we intended to enrol 35 PICU children aged between 0 to 15 years, with the aim of 
reliably detecting a 5% change in QF thickness. A sample size of 35 critically ill children was 
calculated based on previous literature and expected measurement variability within patients 
(12,14). The study was approved by each of the institutional research ethics committees (France 
ANSM: 2015-A01158-41; UK: 13/LO/0974). 
Measurement of QF thickness:  
Ultrasonographic examination was performed using B-mode ultrasonoraphy with either the Vivid S6 
(GE Healthcare, Little Chalfont United Kingdom) or the SonoSite EDGE (Fujifilm sonosite, Bothel, 
USA), in Lyon and Cambridge respectively. We used a linear transducer which frequency was 
adapted according to the accumulative thickness of thigh muscle and fat, ranging from 9 to 13 Hz. 
The measurements were performed strictly perpendicularly to the skin plane in order to limit 
oblique scanning related measurement errors, and with an excessive amount of gel (to ensure no 
direct transducer-skin contact, thus avoiding any inadvertent compression of the thigh by the 
operator). QF muscle is composed of 4 heads, 2 of which (rectus femoris and vastus intermedius 
muscles) are located anteriorly. QF thickness was defined as the sum of the anterior thickness of 
these two heads (see figure 1). 
Measurements were obtained whilst recruited children were either sedated or fully cooperative in 
order to obtain muscle relaxation, therefore avoiding the confounding effects of muscle contraction 
on measured QF thickness. In order to obtain the most accurate QF thickness and maintain 
consistency for all children, each patient was positioned in a supine position and measurements of 
only one leg were taken. On each occasion, the leg was fully extended and positioned in neutral 
rotation whilst external compression of the muscle was avoided to limit artefactual deformation of 
the muscle shape (this included removal of positioning aids and pillows). To overcome the 
progressive increase in thickness of the anterior QF muscle, we used a measuring tape to identify the 
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widest portion of the thigh and recorded the distance of this point from the superior tip of the 
patella (identified to be the most accessible and consistent landmark in this population). Using an 
indelible marker, we then marked this point to ensure that all subsequent measurements were 
taken at exactly the same location. 
Operators: Within the intra-operator repeatability study which was conducted in Lyon, France, one 
single reference operator (FV) performed all measurement sets   twice consecutively for each 
patient (procedure detailed below); paired results were then compared. The reference operator had 
previously been trained by a pediatric radiologist, outside of this study. 
Prior to the commencement of the inter-operator reproducibility study, all operators (DY, UP, MJ, 
NP, FC, FB) were firstly trained outside of the study by the reference operator. The additional 
operator’s involvement in the study was deemed suitable once the reference operator had 
supervised 4 accurate measurement sessions. 
Within the inter-operator reproducibility study, conducted in both Lyon and Cambridge, the 
reference operator performed the first set of measurements, which was immediately followed by a 
second set of measurements completed by another operator. This procedure was repeated for all 
patients to ensure consistency was maintained throughout. In both intra- and inter-operator studies, 
the second set of measurements was done blind to the results of the first set. 
Procedure: Each operator performed a set of 4 measurements of QF muscle anterior thickness. First 
a transverse measurement was performed (transducer placed perpendicularly to thigh axis), then a 
longitudinal one (transducer placed parallel to thigh axis); both measurements were repeated once. 
QF thickness was measured vertically on the image, from the outer cortex of the femur to the 
internal border of the QF fascia, as shown on figure 1. Measurements of reference and additional 
operators were compared. Averages of 2 measurements (obtained in the same angle and in different 
angles) and of the 4 measurements were then calculated in order to account for operator-related 
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error, and compared to averages of the measurement set performed by the second operator 
(following the same protocol). 
Further to the inter- and intra- operator repeatability studies, we also designed a QF measurement 
protocol which would enable the accurate detection of a 5% change in QF muscle thickness during 
the course of a patient stay on PICU. We used a prospective observational study of 17 children 
enrolled between April and May 2016 from one PICU (Cambridge, UK). These patients were 
prospectively recruited under the inclusion criteria previously described: children admitted to PICU 
aged between 0 to 15 years, fully sedated or cooperative. Due to the short-longitudinal nature of 
this observational study, patients were only recruited if it was anticipated that their stay on PICU  
would be longer than 4 days. QF thickness monitoring was discontinued when children were no 
longer sufficiently sedated or cooperative for accurate measurement to take place. Patients 
presenting with a known history of neuromuscular disease were excluded from the study. Wherever 
possible, QF muscle thickness was measured on a daily basis, following the above described 
protocol. Muscle wasting would be considered if QF thickness decreased by more than 5% over PICU 
stay (which would correspond to the limit of our ultrasound measurement protocol reliability). Our 
first endpoints aimed to compare admission values, named time-point-a (TP-a) and obtained within 
the first 24 hours after PICU admission, to time-point-day-5 (TP-b) values (obtained between day-4 
and day-5), and to time-point-c (TP-c) values which corresponded to the final measurement 
considered accurate according to our protocol (namely when the patient was fully sedated or 
cooperative). We also compared indexed values of QF thickness measurement to admission body 
weight. 
Certain characteristics were recorded for all patients, including age, gender, admission weight, 
height, body mass index z-score (WHO reference), and primary diagnosis. Potential risks factors for 
muscle wasting were also recorded, exploring each feature of muscle wasting physiopathology: 
disuse atrophy (length of ventilation, mechanical ventilation duration, use of sedation and neuro-
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blocking agents), starvation (energy-protein intake deficits (15)), acute muscle wasting (PELOD2 
score, highest CRP, length of PICU stay), and cachexia (underlying disease). No standardized physical 
therapy intervention was conducted for all patients during the study, but rather each patient is 
assessed and treated individually. Study protocol was approved by the respective UK and French 
Institutional Review Boards, who waived the need for informed consent. 
 
Statistical analysis: Pearson correlation coefficient was used to identify associated factors to QF 
thickness. Intra-operator repeatability was assessed using the Bland-Altman method. The bias was 
quantified as the mean relative difference between two repeated measurements carried out by the 
same operator. The lower and upper limits of variability were calculated as the values at 2 standard 
deviations below the mean relative difference and at 2 standard deviations over the mean relative 
difference respectively.  The analysis was carried out for each of the 4 measurements (2 longitudinal 
and 2 transverse), but also for the mean of 2 measurements (longitudinal-longitudinal, transverse-
transverse, or longitudinal-transverse) and the mean of 4 measurements. The intra-operator 
repeatability was quantified by the coefficient of variation with its 95% confidence interval (CI). The 
inter-operator reproducibility of the mean of the 4 measurements was quantified using the intra-
class correlation coefficient. A random-intercept linear model was used to estimate the inter-patient 
variance and the intra-patient variance corresponding to the inter-operator variance. The intra-class 
correlation coefficient was obtained as the ratio of the inter-patient variance on the total variance 
(inter plus intra-patient).  The Bland-Altman method was also used to quantify the reproducibility 
between the reference operator and each of the six fully trained operators. Muscle wasting 
longitudinal study: the paired Wilcoxon test was used to compare TP-a values to TP-b and TP-c 
values respectively. Pearson correlation coefficient was used to estimate and test the link between 
the cumulative energy or protein deficit and the QF thickness difference between two times. A linear 
mixed model with a random effect on intercept and slope was used to quantify the change of QF 
13 
 
thickness over time adjusted on age, gender, BMI z-score, PELOD2 score and highest CRP value. All 
data analysis was carried out using the R software, version 3.1.3. 
 
Results 
Intra- and inter-operator repeatability and reproducibility studies.  
In total, 73 patients were enrolled; 37 children were included in the intra-operator repeatability 
study, and 36 other children in the inter-operator reproducibility study. The overall median (25-75 
inter-quartiles (IQ)) age and weight were 13 (3-98) months and 9.8 (4.6-23.5) kg respectively, and 30 
(41%) were girls (table1). The main reasons for PICU admission were respiratory failure, sepsis, 
trauma and post-operative care. The overall median (25-75 IQ) QF thickness was 1.71 (1.40-2.26) cm. 
QF thickness was positively correlated (p<0.001) with age (r=0.69 IC95%:0.55-0.79), weight (r=0.80; 
IC95%:0.70-0.87), and height (r=0.77; IC95%:0.66-0.85) (see figure 2). Seven operators participated 
to the inter-operator reproducibility study (5 pediatric intensivists and 2 pediatric physical 
therapists). The comparison of any single measurement or 2-measurement sets (longitudinal, 
transverse, or mixed) failed to be reproducible (the coefficient of variation of the 4 measurements 
within a set of 4-measurements was high in children less than 40kg, as shown in figure 3a). Four-
measurement sets comparison are detailed below. 
Intra-operator repeatability study: the mean (+/- standard deviation) difference and relative 
difference between the two means of 4-measurements sets were 0.012 cm (+/-0.49) and 0.36% (+/-
2.5) respectively, with a lower limit and upper limit estimated at -4.5 and +5.2 % respectively, as 
shown in figure 3b. The coefficient of variation was 2.5% (95% CI: [2.0; 3.2]).  Inter-operator 
reproducibility study: the intraclass correlation coefficient was 0.998 (close to 1). The mean (+/- 
standard deviation) difference between the two means of 4-measurement sets performed by the 
reference operator and the first operator was 0.006 cm (+/-0.49). Their mean relative difference was 
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0.5% (+/-2.5), with a lower limit and upper limit estimated at -5.4% and +4.5% respectively. Similar 
results were found for other operators.  
QF thickness decrease in acute critical illness. As we had found satisfying intra- and inter- operator 
repeatability and reproducibility, QF thickness decrease was considered accurate and used as a 
surrogate to muscle wasting. Seventeen children were enrolled  from Cambridge PICU in the muscle 
wasting monitoring study that followed. Their median (25-75 IQ) age and weight were 47 (5-126) 
months and 20 (7.8-29.6) kg respectively, and 2 (11.7%) were girls (table2). Respiratory failure, 
sepsis and brain injury were the most common admission diagnoses. The median (25-75 IQ) PICU 
length of stay of 10 (7-13.5) days allowed for a median of 5 (4-6) measurements per patient.  The 
reference operator performed 84% of the 104 QF measurement sets, and 16% were performed by 3 
different fully trained operators who had previously taken part in the inter- operator reproducibility 
study. 
The median (25-75 IQ) QF thickness was 2.25 (1.72-2.79) cm at admission (TP-a). At TP-b (day 5), QF 
thickness measurement showed a significant (p=0.008) decrease of -9.8% (-13.3 - +0.0). At TP-c (last 
measurement performed), QF thickness had shown further significant (p<0.001) decrease by -13.3% 
(-23.6 - -8.9) as illustrated in figure 4. When considering TP-b and TP-c respectively, 12 (71%) and 15 
(88%) children had more than 5% QF thickness decrease, whilst 7 (41%) and 10 (59%) had more than 
10% QF thickness decrease, and 3 (18%) and 6 (35%) more than 20% QF thickness decrease, as 
shown in figure 5. Additionally, after indexing QF thickness values to admission body weight, we also 
found a significant decrease between TP-a and TP-b (p=0.01) and between TP-a and TP-c (p=0.0005).  
The mean change of QF thickness over time was estimated at -0.05 cm per day (95% CI: [-0.07; -
0.03]; p<0.001). The mean QF thickness increased significantly with age (0.013 cm per 
supplementary month; 95% CI:  [0.01; 0.015]; p<0.001) and BMI z-score (0.02 cm for an increase of 
0.1 unit of z-score 95% CI: [0.01; 0.03]; p=0.004). It decreased significantly with the highest value of 
CRP (-0.002 cm for an increase of 1 unit of CRP; 95% CI: [-0.003; -0.001]; p=0.004). Gender and 
15 
 
Pelod2 score were not significantly linked to the mean QF thickness (p=0.34 and 0.91 respectively). 
No factor was significantly linked to QF thickness change over time.   Correlation between 
cumulative energy or protein deficit and QF thickness decrease was not statistically significant. 
 
Discussion 
In a short-longitudinal study, monitoring of QF thickness over PICU stay showed an early, statistically 
significant, and clinically important decrease, concerning the vast majority of children of all 
admission weight ranges. This was made possible by the development of a reliable QF thickness 
measurement protocol, which demonstrated both sufficient intra- and inter- operator repeatability 
and reproducibility, using average scores for repeated ultrasound measurements in different axes. 
Fivez et al. previously failed to design a measurement protocol offering sufficient intra-operator 
reliability in children on PICU (12). They were unable to accurately detect a change in QF thickness of 
less than 30% which unfortunately is not beneficial in clinical practice. Indeed, early and precise 
recognition of muscle mass change is mandatory for future epidemiological and treatment studies. 
Based on our pilot study, in conjunction with adult literature, a technique which allows for accurate 
detection of a 5% change in muscle mass is recommended (1). One explanation for the negative 
results seen in Fivez et al. study (12) may be that 8 of 30 patients were sedated but not intubated. 
Though the authors state that their patients were adequately sedated for the exam, subtle 
contractions of muscles in sedated but moving patients may transiently increase muscle thickness 
measurements. Similarly, McLeod et al. found high coefficient of variation whilst measuring different 
muscle groups in preterm babies (14). The operator related risk of error may be diminished using the 
average of subsequently repeated measurements, according to a detailed measurement protocol.  
The measurement of the area of rectus femoris or vastus intermedius has been proposed as another 
way to estimate muscle mass. During our pilot training, we faced difficulties in accurately capturing 
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the entire cross-section of these muscles within one single ultrasound image, especially in infants 
and children with low level of fat mass. As a result, this technique was not selected for the study. 
Ultrasonography is a core skill within the PICU intensivist’s daily practice and care. Additionally, the 
learning curve for both experienced and non-experienced team members was quite rapid. This is a 
non-invasive technique, available at the bedside, which requires only a few minutes, in comparison 
to other muscle mass assessment techniques like CT imaging or MRI. This method may therefore be 
utilized in future research and eventually enable muscle mass assessment integration into the 
systematic recommended nutritional status assessment in PICU. 
We did not compare QF thickness ultrasonographic measurement to MRI measurement which is the 
gold standard. In fact, MRI is technically difficult to perform in a critically ill child. Our primary 
outcome was to develop a technique that would allow for the accurate measurement and reliable 
monitoring of change in muscle thickness rather than examine absolute value measurement of 
muscle thickness (12). Similarly, anthropometric measurements, including thigh circumference and 
weight for example, were not compared to ultrasonographic measurements as they may be sensitive 
to fluid shift and fat mass change within this clinical setting. No healthy control group was recruited 
as full cooperation of infants and toddlers, which is essential for good reliability of the technique, 
was not possible. QF was chosen over other muscle groups because of its large thickness and ease of 
accessibility, allowing for more accurate assessment (14). However, it remains an indirect estimation 
of the overall muscle mass. In adults, muscle echogenicity shifts over intensive care stay (using 
greyscale assessment software) has been correlated to muscle wasting and outcomes (16), and has 
been proposed to assess and monitor muscle quality. It was also correlated to histological necrosis 
findings (17). No such data is available in the pediatric setting as it remains difficult to obtain 
parental consent for muscle biopsies. Extrapolation of adult results should be tested and their utility 
in muscle quality monitoring should also be further investigated. 
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The degree of muscle mass change over the course of a PICU admission can be easily and reliably 
estimated using ultrasound measurement of QF thickness. Implementation of this method may 
allow for the early detection and monitoring of muscle wasting over PICU stay in sedated or 
cooperative children. 
PICU-acquired weakness is however, a type of reversible neuro-muscular disease and its assessment 
should comply with the neuro-muscular assessment recommendations. A holistic overview of 
muscle function in relation to patient activity and participation, as described by the disability 
creation process (DCP) model or the WHO International Classification of Functioning (18,19), is 
required rather than simply assessing for degree of muscle wasting in isolation. This would result in 
assessment of muscle wasting and PICU-acquired weakness with an overall approach, focussing not 
only on muscle mass, but also on muscle strength and muscle function, as well as on its 
consequences on daily life. This will allow for further investigation of the correlation between early 
ultrasonography recognition of muscle wasting during PICU stay and its functional outcome. This 
may additionally enable researchers to examine the extent to which adjuncts such as nutritional 
optimization and rehabilitation can minimize muscle wasting and its consequences. 
Our PICU muscle mass monitoring study demonstrates that muscle mass decline is an early and 
extended phenomenon that occurs in most critically ill children. In critically ill adults, Parry et al. (16) 
similarly found a large decrease (30%) of thigh muscle thickness, while Puthucheary et al. (1) found 
that rectus femoris cross sectional area decreased significantly at day 7 of ICU stay (−12.5% [95% CI, 
−35.4% to 24.1%]; P = .002), and continued to decrease at day 10 (−17.7% [95% CI, −25.9% to 8.1%]; 
P < .001). However, muscle wasting is not synonymous with muscle weakness, as shown by the 
higher incidence of ICU muscle weakness or ICU-AW, ranging from 25 to 100% in various studies. 
This also emphasizes the fact that validation of accurate assessment tools and standardization of 
diagnostic protocols are mandatory in this field.  Field-Ridley et al. recently published a large analysis 
of PICU-AW (7), using the data collected in a US register (Virtual PICU System, a clinical database 
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with nationally participating PICUs). Incidence of critical illness myopathy was 0.02%, based on the 
international classification of diseases coding. PICU-AW independent risk factors were identified 
(including age, respiratory and infectious primary diagnosis, mechanical ventilation, renal 
replacement therapy and extra-corporal life support). In this study, PICU-AW was also associated 
with longer length of stay and an increased need for rehabilitation following discharge from PICU. 
However, this study was limited by the voluntary report of PICU-AW into the register without any 
clear overarching PICU-AW definition. This may have led to an underestimation of the extent of 
PICU-AW. Furthermore, the risk factors that were identified should ideally be analysed within the 
spectrum of other confounding factors, such as cumulative energy and protein deficit, cumulative 
doses of neuro-blocking agents and sedative drugs, for example. The extent of inflammation may 
also impact muscle metabolism shift in critical illness. In 2003, Banwell et al. reported an incidence 
of PICU-AW of 1.7%, based on prospective neurological examination of 830 children, assessing 
muscle weakness (8). Electromyography and muscle biopsy performed on 7 and 3 patients 
respectively, confirmed myopathy features, in a majority of them. Banwell et al. identified length of 
stay and post transplantation admission as risk factors for muscle weakness. In addition, the children 
in their sample were found to have prolonged muscle weakness three months after discharge. 
Our intra- and inter-operator reliability study enrolled a large number of children with an extended 
age range, and a wide variety of clinical conditions, thus optimizing potential for wide extrapolation 
of results into other PICUs. When considering clinical application, the results identified in the current 
research, together with those of Fivez et al. (12), emphasize the importance of adherence to a strict 
protocol which includes multiple measurements, and excludes non-cooperative children. This will 
limit per se its use in non-cooperative children especially in the youngest with withdrawn sedation. 
However, our technique should be able to be used in the early hypermetabolic phase. 
Our research findings suggest that ultrasonography used for the assessment of QF muscle thickness 
has good intra-rater reliability. The findings also support the hypothesis that this technique has good 
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inter-rater reproducibility amongst pediatric intensivists and Physical Therapists following 
appropriate training. In this study, only the reference operator received initial training from a 
pediatric radiologist, however he was then able to train additional operators in the clinical setting 
where ultrasonography belongs to intensivists’ daily practice; as replication of the technique was 
good, this approach of dissemination may be implemented in future research and clinical practice.  
The power of the muscle mass monitoring study did not allow for independent risk factor 
recognition. In consequence, it does not yet allow the identification of a specific feature of interest 
that would particularly induce muscle wasting (such as disuse atrophy, fasting, severity of the 
disease, and/or inflammation). Future studies should seek to identify these risk-factors, and to 
correlate the degree of muscle wasting with various outcomes including length and cost of stay, 
mechanical ventilation weaning, muscle function, rehabilitation needs and quality of life.  
Hydration surely impacts on muscle mass and compromises the muscle wasting assessment accuracy 
of our technique. We did not perform muscle biopsies to distinguish the implication in QF thickness 
variations, of muscle wasting itself and of muscle hydration. Assessment of body fluid overload is 
also challenging in the critically ill child: weight is a poor indicator in this setting, as it is influenced by 
both fluid shifts and nutritional status changes, and accuracy of fluid balance between inputs and 
outputs is questionable. The extend of the impact of fluid overload may be balanced by the 
combination of both muscular cell dehydration and muscular extracellular overhydration, as 
described by Gamrin et al. (20,21) and Haussinger et al. (22). In consequence, moderate fluid shifts, 
that are frequent in critically ill children, may not alter QF measurements significantly, as stated by 
Puthucheary et al. (23). However, the use of QF thickness as a surrogate of muscle wasting may not 
be perfectly accurate. 
Accuracy of the technique may be challenged by the magnitude of change of QF thickness in 
neonates or infants, which is expected to be small. Average of two measurements did not show 
sufficient repeatability nor reproducibility in our study. We may hypothesize that averaging more 
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than 2 measurements performed in the same angle (longitudinal or transverse) would have allowed 
for sufficient repeatability and reproducibility and should be tested in a future study. Averaging 
measurements of the same structure from different angle is not commonly proposed in the 
literature. However, in our study the combination of transverse and longitudinal measurements was 
the only successful technique which allowed for good repeatability and reproducibility. 
Finally, QF thickness ultrasound measurement should also be validated against the gold standard 
measurement which is MRI. 
To conclude, multiplane ultrasonography enables QF thickness assessment and monitoring (as a 
potential surrogate to muscle wasting) in the critically ill child. QF thickness decrease is an early 
intense phenomenon that occurs in the majority of critically ill children. Further research is required 
in order to better understand PICU muscle wasting, to define early biomarkers, and to assess its 
impact on long term functional outcomes. 
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Figure Legends  
Figure 1 
Thigh ultrasonography in transverse and longitudinal views in two different patients (0: layer of gel, 
no contact between the transducer and the skin is accepted, to confirm the absence of pressure of 
the transducer on the thigh; 1: skin; 2: fat; 3: quadriceps femoris fascia; 4: rectus femoris head of 
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quadriceps femoris; 5: vastus intermedius head of quadriceps femoris; 6: outer cortex of the femur; 
7: femur). On the transverse view, the femur is easily identified as a hyper-echogenic semi-circle, 
which has to be in the centre of the image; quadriceps femoris thickness is measured vertically from 
the upper border of femur cortex, to the under border of quadriceps femoris fascia. On the 
longitudinal view, the femur is identified as a roughly horizontal hyper-echogenic row; the same 
measurement technique is followed, the centre of the image corresponding to the centre of the 
transducer that has to be located on the adequate marked skin location. The transducer has to be 
strictly perpendicular to the skin. 
Figure 2 
Average Quadriceps Femoris (QF) thickness according to patients’ body weight (intra- and inter- 
operator reproducibility study). Red circles and blue dots represent measurements performed by the 
reference operator and other operators respectively 
Figure 3a and 3b 
Figure 3a: Coefficient of variation of quadriceps femoris thickness measurement, within a set of 4 
measurements, according to patient’s weight. Figure 3b: Bland-Altman plots: Intra-operator 
repeatability of quadriceps femoris measurement (sets of 4 measurements) 
Figure 4 
Quadriceps femoris thickness (in cm) monitoring at admission (TP-a), day5 (TP-b) and at last 
measurement performed (TP-c). Data are presented in cm +/- 2 standard errors (SE). 
Figure 5 
Monitoring over PICU stay of Quadriceps femoris thickness (cm), assessed by thigh ultrasonography. 
Each of 17 lines represents one of the 17 children enrolled in the PICU muscle wasting longitudinal 
study. It is noticeable that the decrease of muscle thickness over stay is almost constant but not 
linear and subject to fluctuations. These fluctuations are related to errors of measurement (within 
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the 5% change reliability of the technique) and eventually to patients’ specific conditions (e.g. severe 
overhydration). TP-a: admission; TP-b: day 5; TP-c: last measurement performed. 
